These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24486428)

  • 1. Opiorphin increases blood pressure of conscious rats through renin-angiotensin system (RAS).
    Fang Y; Li S; Zhou H; Tian X; Lv S; Chen Q
    Peptides; 2014 May; 55():47-51. PubMed ID: 24486428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects and underlying mechanisms of human opiorphin on cardiovascular activity in anesthetized rats.
    Tian XZ; Chen Y; Bai L; Luo P; Du XJ; Chen Q; Tian XM
    Eur J Pharmacol; 2015 Feb; 749():32-8. PubMed ID: 25460028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of human opiorphin on food intake and water intake in mice following central administration.
    Chen Y; Tian XZ; Bai L; Liu ZQ; Xiao XP; Liu P; Li XK
    Neurosci Lett; 2017 Feb; 641():62-69. PubMed ID: 28104434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Activation of the renin-angiotensin system and blood pressure variability in rats].
    Blanc J; Lambert G; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K; Inukai T
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular hypertrophy in diabetic spontaneously hypertensive rats: optimizing blockade of the renin-angiotensin system.
    Lassila M; Davis BJ; Allen TJ; Burrell LM; Cooper ME; Cao Z
    Clin Sci (Lond); 2003 Apr; 104(4):341-7. PubMed ID: 12653675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure.
    Reaux A; Iturrioz X; Vazeux G; Fournie-Zaluski MC; David C; Roques BP; Corvol P; Llorens-Cortes C
    Biochem Soc Trans; 2000; 28(4):435-40. PubMed ID: 10961935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valsartan, a specific angiotensin II receptor blocker, inhibits pancreatic fluid secretion via vagal afferent pathway in conscious rats.
    Yamamoto M; Wei L; Otani M; Harada M; Otsuki M
    Regul Pept; 2012 Oct; 178(1-3):80-5. PubMed ID: 22796317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal angiotensin II in humans reduces blood pressure when angiotensin II type 1 receptors are blocked.
    Derad I; Sayk F; Lehnert H; Marshall L; Born J; Nitschke M
    Hypertension; 2014 Apr; 63(4):762-7. PubMed ID: 24420549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade.
    Feng TC; Ying WY; Hua RJ; Ji YY; de Gasparo M
    J Renin Angiotensin Aldosterone Syst; 2001 Mar; 2(1):19-24. PubMed ID: 11881060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
    Ohlstein EH; Gellai M; Brooks DP; Vickery L; Jugus J; Sulpizio A; Ruffolo RR; Weinstock J; Edwards RM
    J Pharmacol Exp Ther; 1992 Aug; 262(2):595-601. PubMed ID: 1501114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 3rd communication: hemodynamic effects of valsartan in rats and dogs.
    Hayashi N; Yamamoto S; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):620-5. PubMed ID: 9205775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of the renin-angiotensin system to blood pressure variability in hyperthyroid rats].
    Basset A; Blanc J; Elghozi JL
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):905-10. PubMed ID: 10989728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II supports sympathetically mediated vasopressor response to footshock-stress.
    Israel A; Sosa-Canache B
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S84-8. PubMed ID: 11986902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the renin-angiotensin system in endogenous central histamine-induced reversal of critical haemorrhagic hypotension in rats.
    Jochem J
    J Physiol Pharmacol; 2004 Mar; 55(1 Pt 1):39-55. PubMed ID: 15082866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous renin and related short-term blood pressure variability in the conscious rat.
    Blanc J; Lambert G; Elghozi JL
    Eur J Pharmacol; 2000 Apr; 394(2-3):311-20. PubMed ID: 10771297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of valsartan on angiotensin II- and vasopressin-degrading activities in the kidney of normotensive and hypertensive rats.
    Prieto I; Martínez JM; Hermoso F; Ramírez MJ; de Gasparo M; Vargas F; Alba F; Ramírez M
    Horm Metab Res; 2001 Sep; 33(9):559-63. PubMed ID: 11561217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.